JSE Sens

ADCOCK INGRAM HOLDINGS LIMITED - Changes to the board of directors

14 August 2019 - 11:04 AM
AIP
Changes to the board of directors

Adcock Ingram Holdings Limited
(Registration number 2007/016236/06)
(Incorporated in the Republic of South Africa)
Share code: AIP
ISIN: ZAE000123436
("Adcock Ingram" or "the Company")


CHANGES TO THE BOARD OF DIRECTORS

In accordance with paragraph 3.59 of the Listings Requirements of the JSE Limited,
Shareholders are advised of the appointment of Ms Debbie Ransby and Dr Sibongile Gumbi to
serve as independent non-executive directors on the Adcock Ingram Board of Directors
effective 13 August 2019.

ABRIDGED CVS

Ms Debbie Ransby
Ms Ransby is a qualified CA(SA) and a member of the Institute of Directors. Debbie previously
worked in various functions at GlaxoSmithKline (GSK) including Finance, Supply Chain and
Administration and led various cross-functional projects. She also worked as Finance Director
at Takeda (formerly Nycomed) before serving as Managing Director. During her 11 years at
Takeda, she managed the Finance function for Africa, and led various projects for the NEMEA
(Near East, Middle East and Africa) region. Debbie is also a qualified executive business coach.

Dr Sibongile Gumbi
Dr Gumbi is the Founder and CEO of iVacBio, a company involved in the manufacture of animal
health products. She holds a PhD in Pharmacology from the University of Cape Town and MBA
from IMD, Switzerland. She is a Fellow of the eighth class of the African Leadership Initiative
and a member of its associated Global Leadership Network. Sibongile is a specialist in
technology and innovation management having worked in several leadership positions for local
and international organisations concerned with science, technology and innovation.

The Board congratulates Debbie and Sibongile on their appointments and wishes them well on
the Board.


Midrand

14 August 2019
Sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 14/08/2019 11:04:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.